9FSE

Human ROR2 cysteine-rich domain (CRD) and Kringle domain


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.48 Å
  • R-Value Free: 0.271 
  • R-Value Work: 0.236 
  • R-Value Observed: 0.238 

wwPDB Validation   3D Report Full Report


This is version 1.0 of the entry. See complete history


Literature

Structure and function of the ROR2 cysteine-rich domain in vertebrate noncanonical WNT5A signaling.

Griffiths, S.C.Tan, J.Wagner, A.Blazer, L.L.Adams, J.J.Srinivasan, S.Moghisaei, S.Sidhu, S.S.Siebold, C.Ho, H.H.

(2024) Elife 13

  • DOI: https://doi.org/10.7554/eLife.71980
  • Primary Citation of Related Structures:  
    9FSE

  • PubMed Abstract: 

    The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, brachydactyly B, and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secretion and function. Moreover, using function-activating and -perturbing antibodies against the Frizzled (FZ) family of WNT receptors, we demonstrate the involvement of FZ in WNT5A-ROR signaling. Thus, ROR2 acts via its CRD to potentiate the function of a receptor super-complex that includes FZ to transduce WNT5A signals.


  • Organizational Affiliation

    Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Tyrosine-protein kinase transmembrane receptor ROR2238Homo sapiensMutation(s): 0 
Gene Names: ROR2NTRKR2
EC: 2.7.10.1
UniProt & NIH Common Fund Data Resources
Find proteins for Q01974 (Homo sapiens)
Explore Q01974 
Go to UniProtKB:  Q01974
PHAROS:  Q01974
GTEx:  ENSG00000169071 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ01974
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.48 Å
  • R-Value Free: 0.271 
  • R-Value Work: 0.236 
  • R-Value Observed: 0.238 
  • Space Group: P 32 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 109.554α = 90
b = 109.554β = 90
c = 45.004γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
autoPROCdata reduction
AutoSolphasing
PHASERphasing

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Cancer Research UKUnited KingdomC20724/A26752
Wellcome TrustUnited Kingdom203141/Z/16/Z
Wellcome TrustUnited Kingdom099675/Z/12/Z
Cancer Research UKUnited KingdomDRCRPG-May23/100002
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United States1R35GM119574
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United States1R35GM144341
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United States2P30CA093373-19
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesS10 OD018223

Revision History  (Full details and data files)

  • Version 1.0: 2024-07-10
    Type: Initial release